title: Pegfilgrastim in primary prophylaxis of febrile neutropenia during chemotherapy of relapsed and refractory multiple myeloma: a real-life experience.
authors.affiliation: Hematology - AOU Federico II, Naples, Italy, claudiocerc@hotmail.com.
authors.forename: Claudio
authors.initials: C
authors.lastname: Cerchione
authors.forename: Lucio
authors.initials: L
authors.lastname: Catalano
authors.forename: Anna Emanuele
authors.initials: AE
authors.lastname: Pareto
authors.forename: Marco
authors.initials: M
authors.lastname: Picardi
authors.forename: Fabrizio
authors.initials: F
authors.lastname: Pane
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000970:Antineoplastic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D064147:Febrile Neutropenia / Q000139:chemically induced* / Q000517:prevention & control*; D005260:Female; D000069585:Filgrastim; D016179:Granulocyte Colony-Stimulating Factor / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D008016:Life Change Events; D008297:Male; D008875:Middle Aged; D009101:Multiple Myeloma / Q000188:drug therapy*; D011092:Polyethylene Glycols; D011322:Primary Prevention; D011994:Recombinant Proteins / Q000009:adverse effects / Q000627:therapeutic use
chemical_list: D000970:Antineoplastic Agents; D011994:Recombinant Proteins; D016179:Granulocyte Colony-Stimulating Factor; C455861:pegfilgrastim; D011092:Polyethylene Glycols; D000069585:Filgrastim